Churchill Capital Corp Xi Cl A (CCXI)
Churchill Capital Corp Xi Cl A (CCXI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CCXI | ORKA | CPRX | ||
| Company | Churchill Capital Corp Xi Cl A | Oruka Therapeutics Inc | Catalyst Pharm Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 10.25 | 78.21 | 29.60 | ||
| High | 10.25 | 84.97 | 30.25 | ||
| Low | 10.24 | 72.16 | 28.61 | ||
| Latest | 10.24 | 73.99 | 29.44 | ||
| Change | unch | -2.40 | +0.17 | ||
| % Change | unch | -3.14% | +0.58% | ||
| Volume | 112,200 | 2,954,600 | 2,145,800 | ||
| 20-Day Average Volume | 33,810 | 1,677,305 | 1,855,335 | ||
| Previous Close | 10.24 | 76.39 | 29.27 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 10.20 | 63.98 | 26.05 | ||
| 20-Day Raw Stochastic | 11.63% | 62.14% | 63.53% | ||
| 20-Day Relative Strength | 53.07 | 73.95 | 70.97 | ||
| Weighted Alpha | N/A | +601.16 | +33.95 | ||
| Today's Opinion | N/A | 100% Buy | 100% Buy | ||
| Previous Opinion | N/A | 100% Buy | 100% Buy | ||
| Last Month's Opinion | N/A | 100% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -0.49% since 04/21/26 | +7.23% since 04/21/26 | +14.82% since 04/21/26 | ||
| Low | 10.20 on 04/22/26 | 66.51 on 04/24/26 | 25.55 on 04/22/26 | ||
| High | 10.26 on 04/23/26 | 91.00 on 04/27/26 | 32.56 on 04/27/26 | ||
| 1-Month | |||||
| %Chg | +0.99% since 03/27/26 | +66.34% since 03/27/26 | +25.81% since 03/27/26 | ||
| Low | 10.11 on 03/30/26 | 43.50 on 03/30/26 | 23.05 on 03/30/26 | ||
| High | 11.00 on 04/07/26 | 91.00 on 04/27/26 | 32.56 on 04/27/26 | ||
| 3-Month | |||||
| %Chg | N/A since 02/09/26 | +110.44% since 01/28/26 | +21.65% since 01/28/26 | ||
| Low | 10.07 on 02/09/26 | 31.00 on 02/11/26 | 22.16 on 03/20/26 | ||
| High | 11.00 on 04/07/26 | 91.00 on 04/27/26 | 32.56 on 04/27/26 | ||
| 6-Month | |||||
| %Chg | N/A since 02/09/26 | +169.64% since 10/28/25 | +37.83% since 10/28/25 | ||
| Low | 10.07 on 02/09/26 | 25.23 on 01/05/26 | 20.66 on 11/07/25 | ||
| High | 11.00 on 04/07/26 | 91.00 on 04/27/26 | 32.56 on 04/27/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,709,799 | 3,834,548 | 3,574,570 | ||
| Shares Outstanding, K | 71,356 | 50,197 | 122,124 | ||
| Annual Sales | 32,220,000 | 0 | 588,990,000 | ||
| Annual Net Income | -131,760,000 | -105,430,000 | 214,330,000 | ||
| Last Quarter Sales | 11,760,000 | 0 | 152,610,000 | ||
| Last Quarter Net Income | -31,650,000 | -29,580,000 | 52,700,000 | ||
| 60-Month Beta | 1.22 | -0.54 | 0.67 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.44 on 08/09/22 | -0.45 on 03/12/26 | 0.68 on 02/25/26 | ||
| Earnings Date | 11/08/22 | 05/13/26 | 05/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 10.82 | ||